Washington: Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said he expects the Food and Drug Administration to issue an emergency-use authorization for remdesivir soon to treat Covid-19.
Fauci said that while the FDA has not made a final decision yet, he projects “it’s going to be really quickly.
Speaking during an appearance on the Today show, Fauci said he believes Gilead Sciences, the maker of remdesivir, is committed to make the treatment available “as much as they can, as quickly as they can.”
“I’m pretty confident that that will be the case because I believe they’re committed to trying to get this out as quickly as possible,” Fauci told NBC’s Savannah Guthrie.
A trial of the experimental drug remdesivir showed it might help patients recover more quickly from the infection.
Fauci was optimistic about the results, saying “The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery.”
The government-funded study found that patients who took remdesivir recovered faster than patients who did not. It’s not a home run, but federal officials are keen to provide any hope they can in a pandemic that has infected more than 1 million Americans and killed close to 60,000 of them.
Results from the preliminary trial show remdesivir improved recovery time for coronavirus patients from 15 to 11 days. That’s similar to the effect that the influenza drug Tamiflu has on flu. Tamiflu also doesn’t cure patients quickly, but can reduce how long they are sick.
“Although a 31% improvement doesn’t seem like a knockout 100%, it is very important proof of concept,” Fauci said of remdesivir. “What it has proven is that a drug can block this virus.”
However the WHO said it’s too early to comment on the remdesivir trial results released Wednesday.Read More